Post-Transplant Low-Dose Azacitidine Can Improve Overall Survival in AML/MDS Patients and Is Associated With Decrease Risks of Severe Acute and Chronic GVHD

Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2017.12.383
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Alemtuzumab Markedly Reduces Chronic GVHD Without Affecting Overall Survival in Reduced-Intensity Conditioning Sibling Allo-SCT for Adults With AML

Bone Marrow Transplantation
TransplantationHematology
2008English

The Influence of Stem Cell Source on Chronic-GvHD Free, Leukemia Free Transplant Survival in Pediatric Patients With Acute Myeloid Leukemia

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Phase I Dose Escalation Study of Bortezomib in Combination With Lenalidomide in Patients With Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML)

Leukemia Research
Cancer ResearchOncologyHematology
2013English

Prolonged Responses in Patients With MDS and CMML Treated With Azacitidine and Etanercept

British Journal of Haematology
Hematology
2010English

Sequential HLA-haploidentical Transplantation Utilizing Post-Transplantation Cyclophosphamide for GvHD Prophylaxis in High-Risk and Relapsed/Refractory AML/MDS

American Journal of Hematology
Hematology
2018English

Stabilisation of Acute-On-Chronic Liver Failure Patients Before Liver Transplantation Predicts Post-Transplant Survival

Alimentary Pharmacology and Therapeutics
HepatologyPharmacologyGastroenterology
2018English

Discordant Expression of AC133 and AC141 in Patients With Myelodysplastic Syndrome (MDS) and Acute Myelogeneous Leukemia (AML)

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2000English

CD34+ Selected Ex-Vivo T-Cell Depleted (TCD) Grafts for Allogeneic Hematopoietic Cell Transplantation (Allo-Hsct) Is Associated With Low Incidence of Acute and Chronic Graft-Versus-Host Disease (GVHD) and High Chronic-GVHD/Relapse-Free Survival

Biology of Blood and Marrow Transplantation
TransplantationHematology
2016English

Transplant Conditioning With Treosulfan/Fludarabine With or Without TBI. A Randomized Phase II Trial in Patients With MDS and AML

Biology of Blood and Marrow Transplantation
TransplantationHematology
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy